Harry Welten

Directeur Financier/CFO chez AFFIMED N.V.

Profil

Harry Welten currently works at BioSupport AG, as Director, Kanyos Bio, Inc., as Director, Affimed NV, as Chief Financial Officer from 2023, Horizon Therapeutics Switzerland GmbH, as Member-Management Board, Fondation De l'Hôpital Barrie Memorial, as Member-Foundation Council, HBM Fondation, as Member-Foundation Council, and Affimed GmbH, as Member-Supervisory Board.
Mr. Welten also formerly worked at Novaremed AG, as Chairman from 2018 to 2020, Proteomedix AG, as Chairman, UBS Securities LLC, as Director, Kuros Biosurgery Holding AG, as Director, European Medical Solutions, as Independent Director, Synosia Therapeutics, Inc., as Director, BiognoSYS AG, as Director, Proteomedix AG, as Director, Anokion SA, as Director, Kuros Biosciences Ltd., as Director in 2018, Kuros Biosciences AG, as Director, Virometix AG, as Director, Synosia Therapeutics AG, as Member-Management Board, Cytos Biotechnology AG, as Chief Financial Officer & Executive Vice President from 2011 to 2012, and Arpida AG, as Chief Financial Officer & Senior Vice President in 2009.
Mr. Welten received his undergraduate degree and Masters Business Admin degree from The Trustees of Columbia University in The City of New York.

Postes actifs de Harry Welten

Sociétés	Poste	Début
AFFIMED N.V.	Directeur Financier/CFO	31/12/2023
Affimed GmbH	Directeur/Membre du Conseil	-
HBM Fondation	Corporate Officer/Principal	-
Kanyos Bio, Inc.	Directeur/Membre du Conseil	-
Fondation De l'Hôpital Barrie Memorial	Corporate Officer/Principal	-
BioSupport AG	Directeur/Membre du Conseil	-
Horizon Therapeutics Switzerland GmbH	Corporate Officer/Principal	-

Anciens postes connus de Harry Welten

Sociétés	Poste	Fin
Virometix AG	Président	02/10/2024
EUROPEAN MEDICAL SOLUTIONS	Directeur/Membre du Conseil	18/05/2020
░░░░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░